A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.

Project: Research

StatusActive
Effective start/end date28/08/1931/12/21

Keywords

  • Gastroenterology
  • Ulcerative Colitis
  • Clinical trial